AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/16/2024 | Press release | Distributed by Public on 05/16/2024 06:31
Please select the service you want to use:
Smartlinks | PharmaSGP Holding SE | Company News | Shareholders | Shareholder Meeting | Securities Issuers | Beauty and Personal Care Retailers | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Tradegate Exchange | XETRA | SIGMA X MTF
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact